In spite of the lack of colonic inflammation in the WT groups (Fig. 1), however, splenomegaly was clearly evident in both IL-10−/− and WT mice after IL-33 treatment (Suppl. Fig. 1B). This evidence concerns the gene IL33 and Splenomegaly.